- Motley Fool•2 days ago
Does Opko Health's recent clinical setback hurt it in a head-to-head comparison with Qiagen? Or does it actually help?
- Investopedia•6 days ago
After a disappointing 2016, Opko hopes to spring back with solid objectives set for 2017.
- Motley Fool•8 days ago
Opko Health talks about its momentum and a second chance for its human growth hormone at the J. P. Morgan Healthcare Conference.
OPK : Summary for Opko Health, Inc. - Yahoo Finance
Opko Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||8.61 x 200|
|Ask||8.72 x 700|
|Day's Range||8.62 - 8.81|
|52 Week Range||7.42 - 12.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||36.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|